Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)Giuseppe Mancia, Morris Brown, Alain Castaigne, et al.Archives of Internal Medicine|December 15, 2004
Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trialPeter W de Leeuw, Luis M Ruilope, Christopher R Palmer, et al.BMJ Open|May 15, 2016
General practitioners' justifications for therapeutic inertia in cardiovascular prevention: an empirically grounded typologyJean-Pierre Lebeau, Jean-Sébastien Cadwallader, Hélène Vaillant-Roussel, et al.BMC Family Practice|July 21, 2016
Impact of patient education on chronic heart failure in primary care (ETIC): a cluster randomised trialHélène Vaillant-Roussel, Catherine Laporte, Bruno Pereira, et al.Journal of Hypertension|October 3, 2002
The Framingham prediction rule is not valid in a European population of treated hypertensive patientsSylvie Bastuji-Garin, Anne Deverly, Dominique Moyse, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR studyAnne Crochard, Abdelkader El Hasnaoui, Denis Pouchain, et al.BMC Family Practice|December 26, 2014
Patient education in chronic heart failure in primary care (ETIC) and its impact on patient quality of life: design of a cluster randomised trialHélène Vaillant-Roussel, Catherine Laporte, Bruno Pereira, et al.Journal of the American College of Cardiology|April 20, 2004
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) studyJean L Rouleau, Ellen B Roecker, Michal Tendera, et al.European Journal of Heart Failure|February 28, 2004
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudyFranz Hartmann, Milton Packer, Andrew J S Coats, et al.Circulation|September 24, 2004
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialFranz Hartmann, Milton Packer, Andrew J S Coats, et al.Pageof 5